The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Jul. 28, 2026
Filed:
Jul. 03, 2020
Applicant:
Nanjing Immunophage Biomedical Co., Ltd., Jiangsu, CN;
Inventors:
Guohuang Fan, Nanjing, CN;
Hongyu Yang, Nanjing, CN;
Kin Chiu Fong, Nanjing, CN;
Jianfei Wang, Nanjing, CN;
Assignee:
Nanjing Immunophage Biomedical Co., Ltd., Nanjing, CN;
Primary Examiner:
Int. Cl.
CPC ...
C07D 241/04 (2006.01); A61K 45/06 (2006.01); C07C 311/46 (2006.01); C07D 205/04 (2006.01); C07D 207/09 (2006.01); C07D 207/16 (2006.01); C07D 209/48 (2006.01); C07D 211/12 (2006.01); C07D 211/14 (2006.01); C07D 211/28 (2006.01); C07D 211/32 (2006.01); C07D 211/60 (2006.01); C07D 215/36 (2006.01); C07D 231/56 (2006.01); C07D 235/08 (2006.01); C07D 239/42 (2006.01); C07D 239/93 (2006.01); C07D 241/44 (2006.01); C07D 243/08 (2006.01); C07D 265/30 (2006.01); C07D 265/36 (2006.01); C07D 311/46 (2006.01); C07D 401/12 (2006.01);
U.S. Cl.
CPC ...
C07D 241/04 (2013.01); A61K 45/06 (2013.01); C07C 311/46 (2013.01); C07D 205/04 (2013.01); C07D 207/09 (2013.01); C07D 207/16 (2013.01); C07D 209/48 (2013.01); C07D 211/12 (2013.01); C07D 211/14 (2013.01); C07D 211/28 (2013.01); C07D 211/32 (2013.01); C07D 211/60 (2013.01); C07D 215/36 (2013.01); C07D 231/56 (2013.01); C07D 235/08 (2013.01); C07D 239/42 (2013.01); C07D 239/93 (2013.01); C07D 241/44 (2013.01); C07D 243/08 (2013.01); C07D 265/30 (2013.01); C07D 265/36 (2013.01); C07D 401/12 (2013.01);
Abstract
The present invention provides compounds of Formula (I) which can be used as CCR8 inhibitors, which can be used as treatment or prevention of cancer using CCR8 inhibitors targeted tumor specific T regulatory cells.
Fan, Guohuang. (2026). Methods and compositions for targeting tregs using ccr8 inhibitors (U.S. Patent No. 12692239). U.S. Patent and Trademark Office. https://idiyas.com/patent/badge/12692239
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile